Weidman Jason R.
Transaction: 06/08/2026
OTHER
Change
0
Price
Not reported
Filing
06/09/2026
Type
OTHER
Teleflex Incorporated
TFX • Medical - Instruments & Supplies
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$6.15B
Growth
5.4%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 5.5Consistent free cash flow · 5/5Manageable debt level · 0.87Healthy liquidity · 2.54Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:40 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$6.15B
52W Range100.18 - 145.00
Beta0.82
Gross Margin56.24%
Oper. Margin12.84%
Profit Margin-45.45%
Debt/Eq0.87
Current Ratio2.54
Quick Ratio2.01
Revenue 5Y5.41%
Price$0.00
Change0.00%
Market Cap$6.15B
52W Range100.18 - 145.00
Beta0.82
Gross Margin56.24%
Oper. Margin12.84%
Profit Margin-45.45%
Debt/Eq0.87
Current Ratio2.54
Quick Ratio2.01
Revenue 5Y5.41%
Target$152.57
Target Median$155.00
Target Range140.00 - 160.00
Volume1.20M
Avg Volume593.95K
EPS Surprise0.18
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
35/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
67/100
Why this score▼
Positive free cash flow · 5.5Consistent free cash flow · 5/5Manageable debt level · 0.87Healthy liquidity · 2.54Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$140.00
Mean
$152.57
Median
$155.00
High
$160.00
Insider Transactions
Recent executive and insider activity
Weidman Jason R.
Transaction: 06/08/2026
BUY
Change
+26,071
Price
$131.74
Filing
06/09/2026
Type
BUY
Weidman Jason R.
Transaction: 06/08/2026
BUY
Change
+53,983
Price
Not reported
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Weidman Jason R. | OTHER | 0 | Not reported | 06/08/2026 | 06/09/2026 |
| Weidman Jason R. | BUY | +26,071 | $131.74 | 06/08/2026 | 06/09/2026 |
| Weidman Jason R. | BUY | +53,983 | Not reported | 06/08/2026 | 06/09/2026 |
| RANDLE STUART A | BUY | +2,192 | $131.74 | 06/08/2026 | 06/09/2026 |
| RANDLE STUART A | BUY | +995 | Not reported | 06/08/2026 | 06/09/2026 |
| RANDLE STUART A | SELL | -4,054 | $129.84 | 06/07/2026 | 06/09/2026 |
| Patil Neena M | BUY | +2,397 | $129.71 | 05/15/2026 | 05/19/2026 |
| Patil Neena M | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| TOKICH MICHAEL J | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| TOKICH MICHAEL J | BUY | +4,793 | $129.71 | 05/15/2026 | 05/19/2026 |
| Duncan Candace H | BUY | +2,397 | $129.71 | 05/15/2026 | 05/19/2026 |
| Duncan Candace H | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| HAGGERTY GRETCHEN R | BUY | +2,397 | $129.71 | 05/15/2026 | 05/19/2026 |
| HAGGERTY GRETCHEN R | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| Krakauer Andrew A | BUY | +2,397 | $129.71 | 05/15/2026 | 05/19/2026 |
| Krakauer Andrew A | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| Ryu Jaewon | BUY | +2,397 | $129.71 | 05/15/2026 | 05/19/2026 |
| Ryu Jaewon | BUY | +1,090 | Not reported | 05/15/2026 | 05/19/2026 |
| TOKICH MICHAEL J | OTHER | 0 | Not reported | 05/15/2026 | 05/18/2026 |
| RANDLE STUART A | SELL | -289 | $133.06 | 05/09/2026 | 05/12/2026 |